{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:08:33Z","timestamp":1787069313935,"version":"build-2736575974"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370455"],"award-info":[{"award-number":["82370455"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82430014"],"award-info":[{"award-number":["82430014"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["20220484151"],"award-info":[{"award-number":["20220484151"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"DOI":"10.1038\/s41423-026-01417-8","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T09:28:22Z","timestamp":1776850102000},"page":"654-672","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Interleukin enhancer binding factor 3 exacerbates cardiac inflammation and injury following myocardial infarction by inhibiting Lys48-linked ubiquitination on HNRNPA2B1 in macrophages"],"prefix":"10.1038","volume":"23","author":[{"given":"Xu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long-hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-qing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-rui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-min","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-fei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9501-2546","authenticated-orcid":false,"given":"Ming-xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"1417_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0140-6736(16)30677-8","volume":"389","author":"GW Reed","year":"2017","unstructured":"Reed GW, Rossi JE, Cannon CP. Acute myocardial infarction. Lancet. 2017;389:197\u2013210.","journal-title":"Lancet"},{"key":"1417_CR2","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","volume":"394","author":"M Zhou","year":"2019","unstructured":"Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;394:1145\u201358.","journal-title":"Lancet"},{"key":"1417_CR3","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1161\/CIRCULATIONAHA.123.065506","volume":"149","author":"S Zhang","year":"2024","unstructured":"Zhang S, Zhang Y, Duan X, Wang B, Zhan Z. Targeting NPM1 epigenetically promotes postinfarction cardiac repair by reprogramming reparative macrophage metabolism. Circulation. 2024;149:1982\u20132001.","journal-title":"Circulation"},{"key":"1417_CR4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41392-024-01840-1","volume":"9","author":"R Chen","year":"2024","unstructured":"Chen R, Zhang H, Tang B, Luo Y, Yang Y, Zhong X, et al. Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets. Signal Transduct Target Ther. 2024;9:130.","journal-title":"Signal Transduct Target Ther"},{"key":"1417_CR5","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1161\/CIRCRESAHA.124.323658","volume":"134","author":"I Hilgendorf","year":"2024","unstructured":"Hilgendorf I, Frantz S, Frangogiannis NG. Repair of the infarcted heart: cellular effectors, molecular mechanisms and therapeutic opportunities. Circ Res. 2024;134:1718\u201351.","journal-title":"Circ Res"},{"key":"1417_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.664457","volume":"12","author":"I Kologrivova","year":"2021","unstructured":"Kologrivova I, Shtatolkina M, Suslova T, Ryabov V. Cells of the immune system in cardiac remodeling: main players in resolution of inflammation and repair after myocardial infarction. Front Immunol. 2021;12:664457.","journal-title":"Front Immunol"},{"key":"1417_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s00395-018-0686-x","volume":"113","author":"AJ Mouton","year":"2018","unstructured":"Mouton AJ, DeLeon-Pennell KY, Rivera Gonzalez OJ, Flynn ER, Freeman TC, Saucerman JJ, et al. Mapping macrophage polarization over the myocardial infarction time continuum. Basic Res Cardiol. 2018;113:26.","journal-title":"Basic Res Cardiol"},{"key":"1417_CR8","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1016\/j.jacc.2011.08.034","volume":"58","author":"EA Liehn","year":"2011","unstructured":"Liehn EA, Postea O, Curaj A, Marx N. Repair after myocardial infarction, between fantasy and reality: the role of chemokines. J Am Coll Cardiol. 2011;58:2357\u201362.","journal-title":"J Am Coll Cardiol"},{"key":"1417_CR9","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1093\/cvr\/cvz336","volume":"116","author":"C Peet","year":"2020","unstructured":"Peet C, Ivetic A, Bromage DI, Shah AM. Cardiac monocytes and macrophages after myocardial infarction. Cardiovasc Res. 2020;116:1101\u201312.","journal-title":"Cardiovasc Res"},{"key":"1417_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52812-6","volume":"15","author":"C Kim","year":"2024","unstructured":"Kim C, Kim H, Sim WS, Jung M, Hong J, Moon S, et al. Spatiotemporal control of neutrophil fate to tune inflammation and repair for myocardial infarction therapy. Nat Commun. 2024;15:8481.","journal-title":"Nat Commun"},{"key":"1417_CR11","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1161\/CIRCRESAHA.124.323817","volume":"134","author":"M Holt","year":"2024","unstructured":"Holt M, Lin J, Cicka M, Wong A, Epelman S, Lavine KJ. Dissecting and visualizing the functional diversity of cardiac macrophages. Circ Res. 2024;134:1791\u2013807.","journal-title":"Circ Res"},{"key":"1417_CR12","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1161\/CIRCRESAHA.119.315807","volume":"127","author":"CK Huang","year":"2020","unstructured":"Huang CK, Dai D, Xie H, Zhu Z, Hu J, Su M, et al. Lgr4 governs a pro-inflammatory program in macrophages to antagonize post-infarction cardiac repair. Circ Res. 2020;127:953\u201373.","journal-title":"Circ Res"},{"key":"1417_CR13","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1161\/CIRCRESAHA.123.324023","volume":"135","author":"CK Huang","year":"2024","unstructured":"Huang CK, Chen Z, Zhou Z, Chen S, Chen L, Li L, et al. RNF149 destabilizes IFNGR1 in macrophages to favor postinfarction cardiac repair. Circ Res. 2024;135:518\u201336.","journal-title":"Circ Res"},{"key":"1417_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pharmthera.2018.01.001","volume":"186","author":"SB Ong","year":"2018","unstructured":"Ong SB, Hern\u00e1ndez-Res\u00e9ndiz S, Crespo-Avilan GE, Mukhametshina RT, Kwek XY, Cabrera-Fuentes HA, et al. Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities. Pharm Ther. 2018;186:73\u201387.","journal-title":"Pharm Ther"},{"key":"1417_CR15","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.7150\/thno.37106","volume":"10","author":"J Li","year":"2020","unstructured":"Li J, Song Y, Jin JY, Li GH, Guo YZ, Yi HY, et al. CD226 deletion improves postinfarction healing by modulating macrophage polarization in mice. Theranostics. 2020;10:2422\u201335.","journal-title":"Theranostics"},{"key":"1417_CR16","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/CIRCRESAHA.123.324114","volume":"135","author":"V Garlapati","year":"2024","unstructured":"Garlapati V, Luo Q, Posma J, Aluia M, Nguyen TS, Grunz K, et al. Macrophage-expressed coagulation factor vii promotes adverse cardiac remodeling. Circ Res. 2024;135:841\u201355.","journal-title":"Circ Res"},{"key":"1417_CR17","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ahj.2011.06.012","volume":"162","author":"PM Ridker","year":"2011","unstructured":"Ridker PM, Thuren T, Zalewski A, Libby P. Interleukin-1\u03b2 inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS). Am Heart J. 2011;162:597\u2013605.","journal-title":"Am Heart J"},{"key":"1417_CR18","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377:1119\u201331.","journal-title":"N Engl J Med"},{"key":"1417_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","volume":"391","author":"PM Ridker","year":"2018","unstructured":"Ridker PM, MacFadyen JG, Everett BM, Libby P, Thuren T, Glynn RJ. Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomized controlled trial. Lancet. 2018;391:319\u201328.","journal-title":"Lancet"},{"key":"1417_CR20","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","volume":"381","author":"JC Tardif","year":"2019","unstructured":"Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med. 2019;381:2497\u2013505.","journal-title":"N Engl J Med"},{"key":"1417_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s11658-023-00491-4","volume":"28","author":"W Zuo","year":"2023","unstructured":"Zuo W, Sun R, Ji Z, Ma G. Macrophage-driven cardiac inflammation and healing: insights from homeostasis and myocardial infarction. Cell Mol Biol Lett. 2023;28:81.","journal-title":"Cell Mol Biol Lett"},{"key":"1417_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41569-022-00823-5","volume":"20","author":"J Yap","year":"2023","unstructured":"Yap J, Irei J, Lozano-Gerona J, Vanapruks S, Bishop T, Boisvert WA. Macrophages in cardiac remodeling after myocardial infarction. Nat Rev Cardiol. 2023;20:373\u201385.","journal-title":"Nat Rev Cardiol"},{"key":"1417_CR23","doi-asserted-by":"crossref","unstructured":"Kim Y, Nurakhayev S, Nurkesh A, Zharkinbekov Z, Saparov A. Macrophage polarization in cardiac tissue repair following myocardial infarction. Int J Mol Sci. 2021;22:2715.","DOI":"10.3390\/ijms22052715"},{"key":"1417_CR24","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/cvr\/cvy244","volume":"115","author":"T Kimura","year":"2019","unstructured":"Kimura T, Tajiri K, Sato A, Sakai S, Wang Z, Yoshida T, et al. Tenascin-C accelerates adverse ventricular remodeling after myocardial infarction by modulating macrophage polarization. Cardiovasc Res. 2019;115:614\u201324.","journal-title":"Cardiovasc Res"},{"key":"1417_CR25","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1161\/CIRCULATIONAHA.121.057549","volume":"145","author":"D Jia","year":"2022","unstructured":"Jia D, Chen S, Bai P, Luo C, Liu J, Sun A, et al. Cardiac resident macrophage-derived legumain improves cardiac repair by promoting clearance and degradation of apoptotic cardiomyocytes after myocardial infarction. Circulation. 2022;145:1542\u201356.","journal-title":"Circulation"},{"key":"1417_CR26","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1093\/eurheartj\/ehv453","volume":"37","author":"M Nahrendorf","year":"2016","unstructured":"Nahrendorf M, Swirski FK. Innate immune cells in ischemic heart disease: does myocardial infarction beget myocardial infarction? Eur Heart J. 2016;37:868\u201372.","journal-title":"Eur Heart J"},{"key":"1417_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2020.100246","volume":"2","author":"G Toda","year":"2021","unstructured":"Toda G, Yamauchi T, Kadowaki T, Ueki K. Preparation and culture of bone marrow-derived macrophages from mice for functional analysis. STAR Protoc. 2021;2:100246.","journal-title":"STAR Protoc"},{"key":"1417_CR28","first-page":"5520","volume":"18","author":"D Quan","year":"2018","unstructured":"Quan D, Huang H. In vitro study of the effects of reprogramming neonatal rat fibroblasts transfected with TBX18 on spontaneous beating in neonatal rat cardiomyocytes. Mol Med Rep. 2018;18:5520\u20136.","journal-title":"Mol Med Rep"},{"key":"1417_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.yjmcc.2023.08.006","volume":"183","author":"Z Xiao","year":"2023","unstructured":"Xiao Z, Wei X, Li M, Yang K, Chen R, Su Y, et al. Myeloid-specific deletion of Capns1 attenuates myocardial infarction injury by restoring mitochondrial function and inhibiting inflammasome activation. J Mol Cell Cardiol. 2023;183:54\u201366.","journal-title":"J Mol Cell Cardiol"},{"key":"1417_CR30","doi-asserted-by":"crossref","unstructured":"Meng M, Cao Y, Zhang Y, Liu S, Zhong Y, Wang D, et al. HnRNPA2B1 aggravates inflammation by promoting m1 macrophage polarization. Nutrients. 2023;15:1555.","DOI":"10.3390\/nu15071555"},{"key":"1417_CR31","doi-asserted-by":"crossref","unstructured":"Wang D, Zheng X, Chai L, Zhao J, Zhu J, Li Y, et al. FAM76B regulates the NF-\u03baB-mediated inflammatory pathway by influencing the translocation of hnRNPA2B1. Elife. 2023;12:e85659.","DOI":"10.7554\/eLife.85659"},{"key":"1417_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-022-01267-x","volume":"14","author":"X Luo","year":"2022","unstructured":"Luo X, Hu Y, Shen J, Liu X, Wang T, Li L, et al. Integrative analysis of DNA methylation and gene expression reveals key molecular signatures in acute myocardial infarction. Clin Epigenetics. 2022;14:46.","journal-title":"Clin Epigenetics"},{"key":"1417_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04143-3","volume":"12","author":"W Liu","year":"2021","unstructured":"Liu W, Shen J, Li Y, Wu J, Luo X, Yu Y, et al. Pyroptosis inhibition improves the symptom of acute myocardial infarction. Cell Death Dis. 2021;12:852.","journal-title":"Cell Death Dis"},{"key":"1417_CR34","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s41418-024-01293-7","volume":"31","author":"Y Liu","year":"2024","unstructured":"Liu Y, Yuan J, Zhang Y, Qin F, Bai X, Sun W, et al. OTUD5 promotes the inflammatory immune response by enhancing MyD88 oligomerization and Myddosome formation. Cell Death Differ. 2024;31:753\u201367.","journal-title":"Cell Death Differ"},{"key":"1417_CR35","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/s41417-023-00607-0","volume":"30","author":"HM Shen","year":"2023","unstructured":"Shen HM, Zhang D, Xiao P, Qu B, Sun YF. E2F1-mediated KDM4A-AS1 upregulation promotes EMT of hepatocellular carcinoma cells by recruiting ILF3 to stabilize AURKA mRNA. Cancer Gene Ther. 2023;30:1007\u201317.","journal-title":"Cancer Gene Ther"},{"key":"1417_CR36","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.freeradbiomed.2025.02.038","volume":"232","author":"S Shi","year":"2025","unstructured":"Shi S, Chen Q, Yang Y, Li Z, Zheng R, Zhang R, et al. HnRNPA2B1 promotes cardiac ferroptosis via m6A-dependent stabilization of PFN2 mRNA in myocardial ischemia\u2012reperfusion injury. Free Radic Biol Med. 2025;232:231\u201343.","journal-title":"Free Radic Biol Med"},{"key":"1417_CR37","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jacbts.2024.01.017","volume":"9","author":"H Cheng","year":"2024","unstructured":"Cheng H, Wu J, Li L, Song X, Xue J, Shi Y, et al. RBM15 protects from myocardial infarction by stabilizing NAE1. JACC Basic Transl Sci. 2024;9:631\u201348.","journal-title":"JACC Basic Transl Sci"},{"key":"1417_CR38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.yjmcc.2022.06.004","volume":"170","author":"L Qi","year":"2022","unstructured":"Qi L, Wang Y, Hu H, Li P, Hu H, Li Y, et al. m(6)A methyltransferase METTL3 participated in sympathetic neural remodeling post-MI via the TRAF6\/NF-\u03baB pathway and ROS production. J Mol Cell Cardiol. 2022;170:87\u201399.","journal-title":"J Mol Cell Cardiol"},{"key":"1417_CR39","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1093\/cvr\/cvab160","volume":"118","author":"R Kumari","year":"2022","unstructured":"Kumari R, Ranjan P, Suleiman ZG, Goswami SK, Li J, Prasad R, et al. mRNA modifications in cardiovascular biology and disease: with a focus on m6A modification. Cardiovasc Res. 2022;118:1680\u201392.","journal-title":"Cardiovasc Res"},{"key":"1417_CR40","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s11010-022-04570-6","volume":"478","author":"J Tang","year":"2023","unstructured":"Tang J, Tang QX, Liu S. METTL3-modified lncRNA-SNHG8 binds to PTBP1 to regulate ALAS2 expression to increase oxidative stress and promote myocardial infarction. Mol Cell Biochem. 2023;478:1217\u201329.","journal-title":"Mol Cell Biochem"},{"key":"1417_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10142-023-01279-7","volume":"24","author":"J Jiang","year":"2023","unstructured":"Jiang J, Zhu J, Qiu P, Ni J, Zhu W, Wang X. HNRNPA2B1-mediated m6A modification of FOXM1 promotes drug resistance and inhibits ferroptosis in endometrial cancer via regulation of LCN2. Funct Integr Genom. 2023;24:3.","journal-title":"Funct Integr Genom"},{"key":"1417_CR42","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","volume":"149","author":"KD Meyer","year":"2012","unstructured":"Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE, Jaffrey SR. Comprehensive analysis of mRNA methylation reveals enrichment in 3\u2019 UTRs and near stop codons. Cell. 2012;149:1635\u201346.","journal-title":"Cell"},{"key":"1417_CR43","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.tcb.2022.10.001","volume":"33","author":"JJ Chan","year":"2023","unstructured":"Chan JJ, Tabatabaeian H, Tay Y. 3\u2019UTR heterogeneity and cancer progression. Trends Cell Biol. 2023;33:568\u201382.","journal-title":"Trends Cell Biol"},{"key":"1417_CR44","doi-asserted-by":"crossref","unstructured":"Ji Z, Guo J, Zhang R, Zuo W, Xu Y, Qu Y, et al. ADAM8 deficiency in macrophages promotes cardiac repair after myocardial infarction via ANXA2-mTOR-autophagy pathway. J Adv Res. 2025;73:483\u201399.","DOI":"10.1016\/j.jare.2024.07.037"},{"key":"1417_CR45","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41392-023-01635-w","volume":"8","author":"Y Liu","year":"2023","unstructured":"Liu Y, Shao YH, Zhang JM, Wang Y, Zhou M, Li HQ, et al. Macrophage CARD9 mediates cardiac injury following myocardial infarction through regulation of lipocalin 2 expression. Signal Transduct Target Ther. 2023;8:394.","journal-title":"Signal Transduct Target Ther"},{"key":"1417_CR46","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.jacc.2025.07.064","volume":"86","author":"A Imbesi","year":"2025","unstructured":"Imbesi A, Greco A, Spagnolo M, Laudani C, Raffo C, Finocchiaro S, et al. Targeting inflammation after acute myocardial infarction. J Am Coll Cardiol. 2025;86:1146\u201369.","journal-title":"J Am Coll Cardiol"},{"key":"1417_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2025.102757","volume":"109","author":"AL Li","year":"2025","unstructured":"Li AL, Guo KZ, Yu LR, Ge J, Zhou W, Zhang JP. Intercellular communication after myocardial infarction: Macrophage as the centerpiece. Aging Res Rev. 2025;109:102757.","journal-title":"Aging Res Rev"},{"key":"1417_CR48","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/wrna.1270","volume":"6","author":"S Castella","year":"2015","unstructured":"Castella S, Bernard R, Corno M, Fradin A, Larcher JC. Ilf3 and NF90 function in RNA biology. Wiley Interdiscip Rev RNA. 2015;6:243\u201356.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"1417_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-02171-4","volume":"21","author":"TW Chan","year":"2020","unstructured":"Chan TW, Fu T, Bahn JH, Jun HI, Lee JH, Quinones-Valdez G, et al. RNA editing in cancer impacts mRNA abundance in immune response pathways. Genome Biol. 2020;21:268.","journal-title":"Genome Biol"},{"key":"1417_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2025.150071","volume":"1871","author":"T Lin","year":"2026","unstructured":"Lin T, Chen X, Huang H, Zhang J, Lin J. DDX3X promotes ILF3 stability to accelerate neuroblastoma progression via M2 macrophage polarization. Brain Res. 2026;1871:150071.","journal-title":"Brain Res"},{"key":"1417_CR51","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/carcin\/bgac091","volume":"44","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Wang K, Yang D, Liu F, Xu X, Feng Y, et al. Hsa_circ_0094606 promotes malignant progression of prostate cancer by inducing M2 polarization of macrophages through PRMT1-mediated arginine methylation of ILF3. Carcinogenesis. 2023;44:15\u201328.","journal-title":"Carcinogenesis"},{"key":"1417_CR52","doi-asserted-by":"crossref","unstructured":"Wang WL, Yen CC, Yen CS, Huang YH, Huang HY, Chen JF, et al. Dysregulation of PCSK9 via m(6)A-dependent epitranscriptomic programs fosters hepatocellular carcinoma progression. Cancer Lett. 2026;640:218255.","DOI":"10.1016\/j.canlet.2026.218255"},{"key":"1417_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401789","volume":"11","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Ye S, Huang S, Cheng Y, Zhang Y, Leng Y, et al. Lefamulin overcomes acquired drug resistance via regulating mitochondrial homeostasis by targeting ILF3 in hepatocellular carcinoma. Adv Sci. 2024;11:e2401789.","journal-title":"Adv Sci"},{"key":"1417_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2025.167919","volume":"1871","author":"T Zhan","year":"2025","unstructured":"Zhan T, Chen M, Zhu Q, Liu M, Tan J, Chen X, et al. ILF3 mediates lipid metabolism to promote pancreatic cancer development by regulating CPT1A-activated PPARa signaling pathway. Biochim Biophys Acta Mol Basis Dis. 2025;1871:167919.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1417_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02192-8","volume":"23","author":"Y Hu","year":"2024","unstructured":"Hu Y, Cai ZR, Huang RZ, Wang DS, Ju HQ, Chen DL. Circular RNA circPHLPP2 promotes tumor growth and anti-PD-1 resistance through binding ILF3 to regulate IL36\u03b3 transcription in colorectal cancer. Mol Cancer. 2024;23:272.","journal-title":"Mol Cancer"},{"key":"1417_CR56","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13046-025-03368-w","volume":"44","author":"J Qi","year":"2025","unstructured":"Qi J, Jiang T, Liu B, Hu Q, Chen J, Ma N, et al. LINC02167 stabilizes KSR1 mRNA in a m(5)C-dependent manner to regulate the ERK\/MAPK signaling pathway and promotes colorectal cancer metastasis. J Exp Clin Cancer Res. 2025;44:121.","journal-title":"J Exp Clin Cancer Res"},{"key":"1417_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07872-x","volume":"16","author":"S Wang","year":"2025","unstructured":"Wang S, Zhu L, Wang Y, Han Y, Wang Q, Yang W, et al. ILF3 promotes colorectal cancer cell resistance to ferroptosis by enhancing cysteine uptake and GSH synthesis by stabilizing SLC3A2 mRNA. Cell Death Dis. 2025;16:549.","journal-title":"Cell Death Dis"},{"key":"1417_CR58","first-page":"745","volume":"27","author":"T Yoshida","year":"2011","unstructured":"Yoshida T, Kato K, Oguri M, Horibe H, Kawamiya T, Yokoi K, et al. Association of polymorphisms of BTN2A1 and ILF3 with myocardial infarction in Japanese individuals with or without hypertension, diabetes mellitus or chronic kidney disease. Int J Mol Med. 2011;27:745\u201352.","journal-title":"Int J Mol Med"},{"key":"1417_CR59","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/eurheartj\/ehad486","volume":"45","author":"MA Matter","year":"2024","unstructured":"Matter MA, Paneni F, Libby P, Frantz S, St\u00e4hli BE, Templin C, et al. Inflammation in acute myocardial infarction: the good, the bad and the ugly. Eur Heart J. 2024;45:89\u2013103.","journal-title":"Eur Heart J"},{"key":"1417_CR60","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.119.002876","volume":"13","author":"M Nikpay","year":"2020","unstructured":"Nikpay M, Soubeyrand S, Tahmasbi R, McPherson R. Multiomics screening identifies molecular biomarkers causally associated with the risk of coronary artery disease. Circ Genom Precis Med. 2020;13:e002876.","journal-title":"Circ Genom Precis Med"},{"key":"1417_CR61","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.4049\/jimmunol.2001235","volume":"206","author":"R Nazitto","year":"2021","unstructured":"Nazitto R, Amon LM, Mast FD, Aitchison JD, Aderem A, Johnson JS, et al. ILF3 is a negative transcriptional regulator of innate immune responses and myeloid dendritic cell maturation. J Immunol. 2021;206:2949\u201365.","journal-title":"J Immunol"},{"key":"1417_CR62","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.rdc.2017.04.002","volume":"43","author":"R Knevel","year":"2017","unstructured":"Knevel R, Huizinga TWJ, Kurreeman F. Genomic influences on susceptibility and severity of rheumatoid arthritis. Rheum Dis Clin North Am. 2017;43:347\u201361.","journal-title":"Rheum Dis Clin North Am"},{"key":"1417_CR63","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.yjmcc.2021.07.011","volume":"161","author":"F Xie","year":"2021","unstructured":"Xie F, Cui QK, Wang ZY, Liu B, Qiao W, Li N, et al. ILF3 is responsible for hyperlipidemia-induced arteriosclerotic calcification by mediating BMP2 and STAT1 transcription. J Mol Cell Cardiol. 2021;161:39\u201352.","journal-title":"J Mol Cell Cardiol"},{"key":"1417_CR64","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s10020-023-00711-9","volume":"30","author":"W Wang","year":"2024","unstructured":"Wang W, Xu R, He P, Xiong Y, Zhao H, Fu X, et al. Role of ATF3 triggering M2 macrophage polarization to protect against the inflammatory injury of sepsis through ILF3\/NEAT1 axis. Mol Med. 2024;30:30.","journal-title":"Mol Med"},{"key":"1417_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51030-4","volume":"15","author":"ZY Wang","year":"2024","unstructured":"Wang ZY, Cheng J, Wang Y, Yuan HT, Bi SJ, Wang SX, et al. Macrophage ILF3 promotes abdominal aortic aneurysm by inducing inflammatory imbalance in male mice. Nat Commun. 2024;15:7249.","journal-title":"Nat Commun"},{"key":"1417_CR66","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1093\/cvr\/cvz050","volume":"115","author":"I Andreadou","year":"2019","unstructured":"Andreadou I, Cabrera-Fuentes HA, Devaux Y, Frangogiannis NG, Frantz S, Guzik T, et al. Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities. Cardiovasc Res. 2019;115:1117\u201330.","journal-title":"Cardiovasc Res"},{"key":"1417_CR67","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.yjmcc.2024.04.004","volume":"190","author":"YM Hou","year":"2024","unstructured":"Hou YM, Xu BH, Zhang QT, Cheng J, Zhang X, Yang HR, et al. Deficiency of smooth muscle cell ILF3 alleviates intimal hyperplasia via HMGB1 mRNA degradation-mediated regulation of the STAT3\/DUSP16 axis. J Mol Cell Cardiol. 2024;190:62\u201375.","journal-title":"J Mol Cell Cardiol"},{"key":"1417_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56859-x","volume":"16","author":"Z Lei","year":"2025","unstructured":"Lei Z, Gu Y, Liu Y, Liu H, Lu X, Chen W, et al. Identification of antiviral RNAi regulators, ILF3\/DHX9, recruit at ZIKV stem loop B to protect against ZIKV induced microcephaly. Nat Commun. 2025;16:1991.","journal-title":"Nat Commun"},{"key":"1417_CR69","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12929-023-00912-8","volume":"30","author":"N Ma","year":"2023","unstructured":"Ma N, Hua R, Yang Y, Liu ZC, Pan J, Yu BY, et al. PES1 reduces CD8(+) T-cell infiltration and immunotherapy sensitivity by interrupting ILF3-IL15 complex in esophageal squamous cell carcinoma. J Biomed Sci. 2023;30:20.","journal-title":"J Biomed Sci"},{"key":"1417_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-023-00389-3","volume":"18","author":"J Zhang","year":"2023","unstructured":"Zhang J, Ma Q, Yu Q, Xiao F, Zhang Z, Feng H, et al. PSMD3-ILF3 signaling cascade drives lung cancer cell proliferation and migration. Biol Direct. 2023;18:33.","journal-title":"Biol Direct"},{"key":"1417_CR71","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.molcel.2019.09.021","volume":"76","author":"F Humphries","year":"2019","unstructured":"Humphries F, Fitzgerald KA. hnRNPA2B1: fueling antiviral immunity from the Nucleus. Mol Cell. 2019;76:8\u201310.","journal-title":"Mol Cell"},{"key":"1417_CR72","doi-asserted-by":"crossref","unstructured":"Wang L, Wen M, Cao X. Nuclear hnRNPA2B1 initiates and amplifies the innate immune response to DNA viruses. Science. 2019;365:eaav0758.","DOI":"10.1126\/science.aav0758"},{"key":"1417_CR73","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cmet.2024.11.014","volume":"37","author":"S Zhang","year":"2025","unstructured":"Zhang S, Cui Z, Zhang D, Zhang D, Jin K, Li Z, et al. Nuclear adenine activates hnRNPA2B1 to enhance antibacterial innate immunity. Cell Metab. 2025;37:413\u201328.e7.","journal-title":"Cell Metab"},{"key":"1417_CR74","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.cell.2022.02.004","volume":"185","author":"Y Li","year":"2022","unstructured":"Li Y, Wang D, Ping X, Zhang Y, Zhang T, Wang L, et al. Local hyperthermia therapy induces browning of white fat and treats obesity. Cell. 2022;185:949\u201366.e19.","journal-title":"Cell"},{"key":"1417_CR75","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1161\/CIRCULATIONAHA.118.033794","volume":"139","author":"P Mathiyalagan","year":"2019","unstructured":"Mathiyalagan P, Adamiak M, Mayourian J, Sassi Y, Liang Y, Agarwal N, et al. FTO-dependent N(6)-methyladenosine regulates cardiac function during remodeling and repair. Circulation. 2019;139:518\u201332.","journal-title":"Circulation"},{"key":"1417_CR76","doi-asserted-by":"crossref","unstructured":"Vausort M, Niedolistek M, Lumley AI, Okni\u0144ska M, Paterek A, M\u0105czewski M, et al. Regulation of N6-methyladenosine after myocardial infarction. Cells. 2022;11:2271.","DOI":"10.3390\/cells11152271"},{"key":"1417_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.149125","volume":"936","author":"Z Li","year":"2025","unstructured":"Li Z, Lao Y, Yan R, Li F, Guan X, Dong Z. N6-methyladenosine in inflammatory diseases: Important actors and regulatory targets. Gene. 2025;936:149125.","journal-title":"Gene"},{"key":"1417_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.670711","volume":"9","author":"J Luo","year":"2021","unstructured":"Luo J, Xu T, Sun K. N6-Methyladenosine RNA Modification in Inflammation: roles, mechanisms, and applications. Front Cell Dev Biol. 2021;9:670711.","journal-title":"Front Cell Dev Biol"},{"key":"1417_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2025.157011","volume":"194","author":"D Srivastava","year":"2025","unstructured":"Srivastava D, Nayak V, Pahari S, Sandeep G, Misra A. Epitranscriptomic regulation of immunity: the role of m6A in shaping immune response dynamics. Cytokine. 2025;194:157011.","journal-title":"Cytokine"},{"key":"1417_CR80","doi-asserted-by":"publisher","first-page":"5091","DOI":"10.1016\/j.apsb.2024.09.008","volume":"14","author":"Y Feng","year":"2024","unstructured":"Feng Y, Chen C, Shao A, Wu L, Hu H, Zhang T. Emerging interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors or degraders as therapeutic agents for autoimmune diseases and cancer. Acta Pharm Sin B. 2024;14:5091\u2013105.","journal-title":"Acta Pharm Sin B"},{"key":"1417_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2022.115954","volume":"440","author":"A Schwendt","year":"2022","unstructured":"Schwendt A, Chammas JB, Chalifour LE. Acute exposure to phthalates during recovery from a myocardial infarction induces greater inflammasome activation in male C57bl\/6 N mice. Toxicol Appl Pharm. 2022;440:115954.","journal-title":"Toxicol Appl Pharm"},{"key":"1417_CR82","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13075-024-03406-6","volume":"26","author":"B Bergstr\u00f6m","year":"2024","unstructured":"Bergstr\u00f6m B, Selld\u00e9n T, Bollmann M, Svensson MND, Ekwall AH. Methotrexate promotes the release of granulocyte-macrophage colony-stimulating factor from rheumatoid arthritis fibroblast-like synoviocytes via autocrine interleukin-1 signaling. Arthritis Res Ther. 2024;26:178.","journal-title":"Arthritis Res Ther"},{"key":"1417_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-63567-x","volume":"14","author":"A M\u00e9noret","year":"2024","unstructured":"M\u00e9noret A, Agliano F, Karginov TA, Hu X, Vella AT. IRAK4 is an immunological checkpoint in neuropsychiatric systemic lupus erythematosus. Sci Rep. 2024;14:16393.","journal-title":"Sci Rep"},{"key":"1417_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102461","volume":"19","author":"LC Su","year":"2020","unstructured":"Su LC, Xu WD, Huang AF. IRAK family in inflammatory autoimmune diseases. Autoimmun Rev. 2020;19:102461.","journal-title":"Autoimmun Rev"},{"key":"1417_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115606","volume":"258","author":"YR Bai","year":"2023","unstructured":"Bai YR, Yang WG, Hou XH, Shen DD, Zhang SN, Li Y, et al. The recent advances in Interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of inflammation and related diseases. Eur J Med Chem. 2023;258:115606.","journal-title":"Eur J Med Chem"},{"key":"1417_CR86","doi-asserted-by":"publisher","first-page":"5521","DOI":"10.1021\/acs.jmedchem.7b00231","volume":"60","author":"KL Lee","year":"2017","unstructured":"Lee KL, Ambler CM, Anderson DR, Boscoe BP, Bree AG, Brodfuehrer JI, et al. Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design. J Med Chem. 2017;60:5521\u201342.","journal-title":"J Med Chem"},{"key":"1417_CR87","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.bbi.2020.05.035","volume":"88","author":"K Pletinckx","year":"2020","unstructured":"Pletinckx K, Krings D, Welbers A, Rider DA, Dunkern TR. Central IRAK-4 kinase inhibition for the treatment of pain following nerve injury in rats. Brain Behav Immun. 2020;88:781\u201390.","journal-title":"Brain Behav Immun"},{"key":"1417_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2024.114794","volume":"377","author":"T Zhao","year":"2024","unstructured":"Zhao T, Zhang X, Cui X, Su S, Li L, Chen Y, et al. Inhibiting the IRAK4\/NF-\u03baB\/NLRP3 signaling pathway can reduce pyroptosis in hippocampal neurons and seizure episodes in epilepsy. Exp Neurol. 2024;377:114794.","journal-title":"Exp Neurol"},{"key":"1417_CR89","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1002\/art.43184","volume":"77","author":"SI Danto","year":"2025","unstructured":"Danto SI, Salganik M, Banerjee A, Hrycaj P, Jashi I, Shojaee N, et al. Efficacy and safety of Zimlovisertib, Ritlecitinib, and Tofacitinib, alone and in combination, in patients with moderate to severe rheumatoid arthritis and an inadequate response to methotrexate. Arthritis Rheumatol. 2025;77:1337\u201348.","journal-title":"Arthritis Rheumatol"},{"key":"1417_CR90","first-page":"387","volume":"19","author":"H Zhang","year":"2025","unstructured":"Zhang H, Liu Z, Qin B, Cheng D, Chen P, Bi X. IRAK4 targeting: a breakthrough approach to combat hidradenitis suppurativa. Biologics. 2025;19:387\u201397.","journal-title":"Biologics"},{"key":"1417_CR91","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1161\/CIRCRESAHA.110.223925","volume":"107","author":"E Gao","year":"2010","unstructured":"Gao E, Lei YH, Shang X, Huang ZM, Zuo L, Boucher M, et al. A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse. Circ Res. 2010;107:1445\u201353.","journal-title":"Circ Res"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01417-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01417-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01417-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T22:02:40Z","timestamp":1780178560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01417-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":91,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["1417"],"URL":"https:\/\/doi.org\/10.1038\/s41423-026-01417-8","relation":{},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"27 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Supplementary Information files have been updated.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}